Tonix Pharmaceuticals Holding Corp. announced that it has entered into a securities purchase agreement with certain investors that it will issue pre-funded warrants for the gross proceeds of $30,000,000 on July 9, 2024. The Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, other obligations of the parties, and termination provisions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5968 USD | -0.75% |
|
-16.23% | -95.37% |
07-09 | Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge | MT |
07-09 | Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-95.37% | 10.42M | |
+7.70% | 101B | |
+7.76% | 42.18B | |
-14.37% | 32.26B | |
+82.32% | 29.79B | |
-12.27% | 16.06B | |
+2.33% | 14.45B | |
-8.56% | 12.01B | |
+182.74% | 10.71B | |
+3.67% | 8.89B |
- Stock Market
- Equities
- TNXP Stock
- News Tonix Pharmaceuticals Holding Corp.
- Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding